Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0000950170-25-024110

Options or other derivatives

  • President & CEO acquired 811,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GOOD JENNIFER L President & CEO 2025-02-18 Grant or award · Stock Option (right to buy) +811,000 811,000 D
Loading xslF345X05/ownership.xml…